DoD Amyotrophic Lateral Sclerosis Therapeutic Idea Award

Post Date

April 1st 2014

Application Due Date

August 20th 2014

Funding Opportunity Number

W81XWH-14-ALSRP-TIA

CFDA Number(s)

12.420

Funding Instrument Type(s)

Cooperative Agreement
Grant

Funding Activity Categories

Science and Technology and other Research and Development

Number of Awards

2

Eligibility Categories

Unrestricted

Funding

• Estimated Total Funding:

  $1280000

• Award Range:

  $None - $None

Grant Description

The Therapeutic Idea Award is designed to promote new ideas that are still in the early stages of development with the potential to yield highly impactful data and new avenues of investigation for novel therapeutics for ALS treatment. This mechanism supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancement in ALS therapeutics. Proposed research projects should include a well-formulated, testable hypothesis based on strong scientific rationale that holds translational potential to improve ALS treatment and/or advances a novel treatment modality. Projects that focus primarily on investigating the pathophysiology of ALS are outside the scientific scope of this mechanism.

Contact Information

• Agency

  Department of Defense

• Office:

  Dept. of the Army -- USAMRAA

• Agency Contact:

  301-682-5507; help@eBRAP.org

• Agency Mailing Address:

  CDMRP Help Desk

• Agency Email Address:

  help@eBRAP.org